Guillaume Dutheuil

This inventor holds 23 USPTO granted patents and 7 published patent applications, plus 6 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Ogeda Sa, Epics Therapeutics, Euroscreen S.a.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guillaume Dutheuil. Retrieved from https://idiyas.com/inventor/guillaume-dutheuil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 52(Granted Patents)

Location History:

Vedrin, BE (2014 - 2023)
Gosselies, BE (2024)

Company Filing History:

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Pharmaceutical Composition

NK-3 Receptor Antagonists

Chiral Synthesis

Triazolo-Pyrazines

Selective Antagonists

N-acyl Derivatives

Dihydro Compounds

Piperidine Derivatives

Hydrazide Compounds

Polymorphs

Synthesis Techniques

Selective Compounds

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528769 - Synthesis of (2S,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid (2026-01-20),

2. 12162849 - Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-deuterated form thereof (2024-12-10),

3. 12091400 - Piperidine derivatives as METTL3 inhibitors (2024-09-17),

4. 12054457 - Polymorphs of (2S,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereof (2024-08-06),

5. 11731974 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2023-08-22),

6. 10941151 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2021-03-09),

7. 10836768 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2020-11-17),

8. 10787458 - Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazines (2020-09-29),

9. 10683295 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2020-06-16),

10. 10544150 - NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders (2020-01-28),

11. 10214533 - N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders (2019-02-26),

12. 10183948 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2019-01-22),

13. 10065961 - Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2018-09-04),

14. 10065960 - NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders (2018-09-04),

15. 10030025 - Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2018-07-24),

Title: Guillaume Dutheuil - Innovative Inventor from Vedrin, BE

Introduction: Guillaume Dutheuil is a talented inventor hailing from Vedrin, Belgium, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Guillaume Dutheuil holds several patents in the areas of renewable energy, sustainable transportation, and smart home technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Guillaume Dutheuil has worked with leading research institutions and tech companies to bring his ideas to life. His dedication to creating solutions for a more sustainable future has earned him recognition in the industry.

Collaborations: Guillaume Dutheuil has collaborated with top engineers, designers, and scientists to develop cutting-edge products that have revolutionized the way we interact with technology. His ability to work in multidisciplinary teams has led to the successful implementation of his inventions.

Conclusion: In conclusion, Guillaume Dutheuil's passion for innovation and commitment to creating a better world through his inventions make him a standout figure in the field of technology. His work continues to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.